| Dr James Michael Isernia, MD | |
|
945 82nd Pkwy, Myrtle Beach, SC 29572-4612 | |
| (843) 497-5929 | |
| (866) 778-9608 |
| Full Name | Dr James Michael Isernia |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Location | 945 82nd Pkwy, Myrtle Beach, South Carolina |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144281148 | NPI | - | NPPES |
| 010282900 | Medicaid | VA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 0101054562 (Virginia) | Primary |
| Entity Name | Martinsville Physician Practices Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255380887 PECOS PAC ID: 0143233346 Enrollment ID: O20060710000176 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.
A new study reports that the risk of transmitting SARS-CoV-2 through such fomites is very low.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
Results of the world's first publicly funded randomized controlled clinical trial of spinal cord stimulation, being presented today at the 12th World Congress of the International Neuromodulation Society, conclude that a fully powered clinical trial is feasible in refractory chronic angina pectoris, a disabling and persistent chronic pain condition.
Mutations to the spike protein and receptor-binding domain are responsible for these changes in immunogenic profile, and in a paper recently uploaded to the open access journal Antibiotics by Ambrose et al. (May 6th, 2021) these mutations are correlated with various disease parameters by in silico methods, finding that particular features are responsible for the increased infectiousness and lesser disease severity observed in these lineages.
› Verified 5 days ago
| Entity Name | Apogee Medical Group Virginia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861660540 PECOS PAC ID: 0345310256 Enrollment ID: O20080604000498 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.
A new study reports that the risk of transmitting SARS-CoV-2 through such fomites is very low.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
Results of the world's first publicly funded randomized controlled clinical trial of spinal cord stimulation, being presented today at the 12th World Congress of the International Neuromodulation Society, conclude that a fully powered clinical trial is feasible in refractory chronic angina pectoris, a disabling and persistent chronic pain condition.
Mutations to the spike protein and receptor-binding domain are responsible for these changes in immunogenic profile, and in a paper recently uploaded to the open access journal Antibiotics by Ambrose et al. (May 6th, 2021) these mutations are correlated with various disease parameters by in silico methods, finding that particular features are responsible for the increased infectiousness and lesser disease severity observed in these lineages.
› Verified 5 days ago
| Entity Name | Signify Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689158487 PECOS PAC ID: 3274895263 Enrollment ID: O20210226002383 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.
A new study reports that the risk of transmitting SARS-CoV-2 through such fomites is very low.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
Results of the world's first publicly funded randomized controlled clinical trial of spinal cord stimulation, being presented today at the 12th World Congress of the International Neuromodulation Society, conclude that a fully powered clinical trial is feasible in refractory chronic angina pectoris, a disabling and persistent chronic pain condition.
Mutations to the spike protein and receptor-binding domain are responsible for these changes in immunogenic profile, and in a paper recently uploaded to the open access journal Antibiotics by Ambrose et al. (May 6th, 2021) these mutations are correlated with various disease parameters by in silico methods, finding that particular features are responsible for the increased infectiousness and lesser disease severity observed in these lineages.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr James Michael Isernia, MD Po Box 3439, North Myrtle Beach, SC 29582-0439 Ph: (843) 839-4447 | Dr James Michael Isernia, MD 945 82nd Pkwy, Myrtle Beach, SC 29572-4612 Ph: (843) 497-5929 |
News Archive
Thermo Fisher Scientific Inc., the world leader in serving science, today reported that it has completed its previously announced acquisition of Phadia, a global leader in blood tests for the clinical diagnosis and monitoring of allergies and autoimmune diseases.
A new study reports that the risk of transmitting SARS-CoV-2 through such fomites is very low.
To better understand what happens during immune reactions in the body, researchers at Tübingen University have developed a new way of labeling T-cells, allowing them to track the T-cell movement in mice using non-invasive positron emission technology (PET).
Results of the world's first publicly funded randomized controlled clinical trial of spinal cord stimulation, being presented today at the 12th World Congress of the International Neuromodulation Society, conclude that a fully powered clinical trial is feasible in refractory chronic angina pectoris, a disabling and persistent chronic pain condition.
Mutations to the spike protein and receptor-binding domain are responsible for these changes in immunogenic profile, and in a paper recently uploaded to the open access journal Antibiotics by Ambrose et al. (May 6th, 2021) these mutations are correlated with various disease parameters by in silico methods, finding that particular features are responsible for the increased infectiousness and lesser disease severity observed in these lineages.
› Verified 5 days ago
Gary A Vukov, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 7900 N Kings Hwy, Myrtle Beach, SC 29572 Phone: 843-449-3381 Fax: 843-839-0275 | |
Gregory L Becker, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 906 Medical Cir, Myrtle Beach, SC 29572 Phone: 843-497-5929 Fax: 843-839-1037 | |
Andrew Peter Mangano, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 920 Doug White Dr Ste 250, Myrtle Beach, SC 29572 Phone: 843-236-1950 Fax: 843-236-1952 | |
Dr. Eunice Luz Guzman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4220 Carolina Exchange Dr, Myrtle Beach, SC 29579 Phone: 843-663-8371 | |
Jacob Hurlan Brazee, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4301 Dick Pond Rd, Myrtle Beach, SC 29588 Phone: 843-652-8100 Fax: 843-652-8122 | |
Dr. Emily Zaruhi Touloukian, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 8121 Rourk St, Myrtle Beach, SC 29572 Phone: 843-692-5000 | |
Dr. Jocelyn A Myers, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 945 82nd Pkwy, Myrtle Beach, SC 29572 Phone: 843-497-5929 |